SyntekaBio has a total of 92 patents globally, out of which 31 have been granted. Of these 92 patents, 57% patents are active. South Korea is where SyntekaBio has filed the maximum number of patents, followed by the United States of America and Europe (EPO). Parallelly, the South Korea seems to be the main focused R&D centre and is the origin country of SyntekaBio.
SyntekaBio was founded in 2009. SyntekaBio is a biotech firm using AI and cloud supercomputing to swiftly discover and develop new drugs, often starting from genomic big data. It is publicly traded on KOSDAQ and combines automated platforms for small molecules, antibodies, cancer vaccines, and clinical genomics in a simple SaaS setup
Do read about some of the most popular patents of SyntekaBio which have been covered by us in this article and also you can find SyntekaBio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over SyntekaBio patent portfolio.
How many patents does SyntekaBio have?
SyntekaBio has a total of 92 patents globally. These patents belong to 38 unique patent families. Out of 92 patents, 53 patents are active.
How Many Patents did SyntekaBio File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Applications Filed | Patents Granted |
| 2025 | – | 1 |
| 2024 | 9 | 3 |
| 2023 | 17 | 1 |
| 2022 | 1 | 4 |
| 2021 | 6 | 1 |
| 2020 | 11 | 4 |
| 2019 | 17 | 5 |
| 2018 | 6 | 1 |
| 2017 | 3 | 3 |
| 2016 | 8 | – |
| 2015 | 3 | 1 |
How many SyntekaBio patents are Alive/Dead?
Worldwide Patents
How Many Patents did SyntekaBio File in Different Countries?
Countries in which SyntekaBio Filed Patents
| Country | Patents |
| South Korea | 60 |
| United States of America | 8 |
| Europe (EPO) | 1 |
| Taiwan | 1 |
Where are Research Centers of SyntekaBio Patents Located?
The Research Centers for SyntekaBio patents is located in South Korea.
Best SyntekaBio Patents
US20190164632A1 is the most popular patent in the SyntekaBio portfolio. It has received 24 citations so far from companies like Nvidia Corporation, Vuno Inc and Kyndryl Inc.
Below is the list of most cited patents of SyntekaBio:
| Publication Number | Citation Count |
| US20190164632A1 | 24 |
| KR101950395B1 | 20 |
| KR101953762B1 | 19 |
| KR101117603B1 | 16 |
| KR100996443B1 | 15 |
| KR101035959B1 | 12 |
| KR101693504B1 | 11 |
| KR101460520B1 | 11 |
| KR101400717B1 | 11 |
| KR102169476B1 | 9 |
What Percentage of SyntekaBio US Patent Applications were Granted?
SyntekaBio (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 has been granted leading to a grant rate of 100%.
Below are the key stats of SyntekaBio patent prosecution at the USPTO.
Which Law Firms are Managing US Patents for SyntekaBio?
| Law Firm | Total Applications | Success Rate |
| Arentfox Schiff Llp | 3 | 100.00% |
| Birch Stewart Kolasch & Birch Llp | 1 | 100.00% |
| Paratus Law Group Pllc | 1 | 100.00% |
What are SyntekaBio’s key innovation segments?
What Technologies are Covered by SyntekaBio?
The chart below distributes patents filed by SyntekaBio in different countries on the basis of the technology protected in patents. It also represents the markets where SyntekaBio thinks it’s important to protect particular technological inventions.
R&D Focus: How has SyntekaBio search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by SyntekaBio?
